These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol. Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839 [TBL] [Abstract][Full Text] [Related]
43. Are PARPs promiscuous? Feijs KLH; Žaja R Biosci Rep; 2022 May; 42(5):. PubMed ID: 35380161 [TBL] [Abstract][Full Text] [Related]
44. A Double-Edged Sword: The Two Faces of PARylation. Kang M; Park S; Park SH; Lee HG; Park JH Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077221 [TBL] [Abstract][Full Text] [Related]
45. Poly-ADP ribosylation in DNA damage response and cancer therapy. Hou WH; Chen SH; Yu X Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352 [TBL] [Abstract][Full Text] [Related]
46. PARG Inhibitors and Functional PARG Inhibition Models. Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742 [TBL] [Abstract][Full Text] [Related]
47. Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Gibson BA; Zhang Y; Jiang H; Hussey KM; Shrimp JH; Lin H; Schwede F; Yu Y; Kraus WL Science; 2016 Jul; 353(6294):45-50. PubMed ID: 27256882 [TBL] [Abstract][Full Text] [Related]
48. Why structure and chain length matter: on the biological significance underlying the structural heterogeneity of poly(ADP-ribose). Reber JM; Mangerich A Nucleic Acids Res; 2021 Sep; 49(15):8432-8448. PubMed ID: 34302489 [TBL] [Abstract][Full Text] [Related]
50. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. Banasik M; Komura H; Shimoyama M; Ueda K J Biol Chem; 1992 Jan; 267(3):1569-75. PubMed ID: 1530940 [TBL] [Abstract][Full Text] [Related]
55. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs. Carter-O'Connell I; Cohen MS Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237 [TBL] [Abstract][Full Text] [Related]
56. A desthiobiotin labelled NAD Rieth S; Spliesgar D; Orth J; Lehner M; Kasprzyk R; Stengel F; Marx A Chembiochem; 2024 Mar; 25(5):e202300797. PubMed ID: 38236015 [TBL] [Abstract][Full Text] [Related]
57. Bioorthogonally Functionalized NAD(+) Analogues for In-Cell Visualization of Poly(ADP-Ribose) Formation. Wallrodt S; Buntz A; Wang Y; Zumbusch A; Marx A Angew Chem Int Ed Engl; 2016 Jun; 55(27):7660-4. PubMed ID: 27080423 [TBL] [Abstract][Full Text] [Related]
58. The PARP Way to Epigenetic Changes. Ummarino S; Hausman C; Di Ruscio A Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804735 [TBL] [Abstract][Full Text] [Related]
59. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors. Putt KS; Hergenrother PJ Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338 [TBL] [Abstract][Full Text] [Related]
60. Crystal structure and biochemical activity of the macrodomain from rubella virus p150. Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]